Tissue levels and displacement of in vivo labelled beta-adrenergic receptors by FM 24, an irreversible or slowly dissociable beta-blocker

European Journal of Pharmacology
G Le FurA Uzan

Abstract

FM 24 [1-(2-exo-bicyclo[3,3,1]hept-2-ylphenoxy)-3-[(1-methylethyl)amino] 2-propanol hydrochloride] and propranolol were compared in mice with respect to their ability to displace in vivo 125I-hydroxybenzylpindolol which is selectively associated with beta-adrenergic receptor binding sites. After a simultaneous i.v. injection of the beta-blockers and 125I-hydroxybenzylpindolol propranolol was more active than FM 24. At an equiblocking dose i.e. a dose which inhibits by 80% the binding of 125I-hydroxybenzylpindolol, FM 24 was still effective after 6 h (40% inhibition in the brain and the heart, 60% in the lung) contrary to propranolol. After oral administration (2 mg/kg), 40% inhibition by FM 24 still persisted at 24 h in the heart whereas no effect of propranolol was detectable at 18 h. As the kinetics of [3H]FM 24 and [3H]propranolol after oral and i.v. administration are not very different we confirmed that the prolonged beta-blocking action of FM 24 was related to a tight irreversible binding to beta-receptors rather than to pharmacokinetic properties of this drug.

References

Jul 1, 1979·Biochemical Pharmacology·P H SchmelckJ Hanoune
Jun 1, 1977·Journal of Pharmacokinetics and Biopharmaceutics·R GomeniP L Morselli

❮ Previous
Next ❯

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·C ThuillezJ F Giudicelli
Aug 1, 1990·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·G CheymolP Jaillon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.